Top

Published in:

01-08-2001 | Research Article

l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure

Authors: Christopher J. Mathias, D.Phil., D.Sc., F.R.C.P., Jean-Michel Senard, M.D., Ph.D., Stefan Braune, M.D., Laura Watson, Atsushi Aragishi, Joelle E. A. Keeling, Michael D. Taylor

Published in: Clinical Autonomic Research | Issue 4/2001

Title: l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure
Authors: Christopher J. Mathias, D.Phil., D.Sc., F.R.C.P.
Jean-Michel Senard, M.D., Ph.D.
Stefan Braune, M.D.
Laura Watson
Atsushi Aragishi
Joelle E. A. Keeling
Michael D. Taylor
Publication date: 01-08-2001
Publisher: Springer-Verlag
Published in: Clinical Autonomic Research / Issue 4/2001
Print ISSN: 0959-9851
Electronic ISSN: 1619-1560
DOI: https://doi.org/10.1007/BF02298955

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

l-threo-dihydroxyphenylserine (l-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: A multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 4/2001

Why do patients have orthostatic symptoms in POTS?

The metabolic, catecholamine and cardiovascular effects of exercise in human sympathetic denervation

Reversible autonomic dysfunction in hyperthyroid patients affects gastric myoelectrical activity and emptying

Research highlights from the literature

Much strain but no gain (in sweat output, that is)

In this issue